Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Top Headlines

MilliporeSigma looks beyond ‘burn and bury’ for single-use recycling

MilliporeSigma is urging industry to recycle single-use technologies, which can be made into speed pumps, parking bollards, and plastic palettes.

Shire turns down Takeda, Allergan toys with buy

Shire has rejected Takeda’s acquisition proposals saying the offers ‘undervalue’ its pipeline and potential for growth.

US FDA halts approval for Pfizer’s trastuzumab biosimilar

The US FDA has issued Pifzer a complete response letter for its proposed biosimilar version of Roche’s cancer drug Herceptin.

Selexis says $2m investment will speed up cell bank delivery time

Cell line developer Selexis has invested in laboratory equipment to reduce delivery times of its high expressing and stable research cell banks.

MilliporeSigma ups single-use mixer volume to 3,000L

MilliporeSigma has launched a new Mobius Power MIX single-use mixing system for buffers, cell culture media powders, and ingredients.

Promotional Features

Content provided by Samsung BioLogics

Samsung BioLogics: The story of the world’s largest biologics manufacturing facility

Samsung BioLogics has moved quickly since it began operating in 2011. The South Korean contract development and manufacturing organization (CDMO) has built a series of progressively larger, more advanced facilities, culminating in its 180,000L “Dream...